HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nanotech Is “More Than Just Tiny,” Requires FDA Regulation – Lawsuit

This article was originally published in The Rose Sheet

Executive Summary

A suit filed in U.S. District Court Dec. 21 by coalition of advocacy groups says FDA's failure to respond "meaningfully" to 2006 citizen petition on nanotechnology violates federal law. Lawsuit asks court to order FDA to respond to their peititon without further delay.


Related Content

FDA Questions Spray Sunscreen Safety, Efficacy & Monograph Status
FDA Takes “Property”-Based Approach To Nanotech, Raises Roof To 1 Micron
Nanomaterial Sunscreens Should Be Designated “New Drugs” – Petition



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts